$3.5 million funds study of rare tumor disorder
David H. Gutmann, MD, PhD, an international leader in neurofibromatosis research, received a $3.5 million grant to study why people with a genetic mutation that causes the genetic disorder known as NF1 develop markedly different signs and symptoms.
|